Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 01, 2006 (Vol. 26, No. 1)

Toxicogenomics Enhances Drug Discovery

Working Toward Improving Hazard Identification and Risk Assessment

  • Adverse health effects resulting from drug toxicity reactions are invariably associated with alterations in gene expression. Toxicogenomics aims at interrogating such changes with the hope of better hazard identification and risk assessment. Microarray technologies continue to lead the pack in toxicogenomics technologies. They, along with other strategies, are ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.